Cel Sci (CVM) Enterprise Value (2010 - 2026)
Cel Sci (CVM) reported Enterprise Value of -$4.65 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $2.35 million a year earlier.
Powered by 
Analysis
Cel Sci (CVM) Enterprise Value (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cel Sci's Enterprise Value came in at -$23.77 million; for FY2025 (ended Sep 30, 2025), it came in at $3.59 million, down 92.1% from FY2024.
- Enterprise Value has declined for five consecutive fiscal years, with a five-year compound annual growth rate of -62.4% (FY2020 to FY2025).
- By fiscal year, Enterprise Value came in at $45.52 million in FY2024 (-17.4%), $55.13 million in FY2023 (-50.6%), $111.57 million in FY2022 (-74.2%) and $432.59 million in FY2021 (-9.5%).
- The fiscal Q3 2026 figure ranks as the lowest quarterly Enterprise Value in data going back to fiscal Q3 2010.
- The high point for year-over-year Enterprise Value in five years was fiscal Q1 2024 (growth of 56.7%); the low point was fiscal Q3 2025 (a decline of 96.2%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $3.91 million (Q2 2026), $3.23 million (Q1 2026) and $5.68 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.65 Mn |
| Mar 31, 2026 | 3.91 Mn |
| Dec 31, 2025 | 3.23 Mn |
| Sep 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | 10.55 Mn |
| Dec 31, 2024 | 17.09 Mn |
| Sep 30, 2024 | 52.77 Mn |
| Jun 30, 2024 | 62.55 Mn |
| Mar 31, 2024 | 97.98 Mn |
| Dec 31, 2023 | 132.80 Mn |
| Sep 30, 2023 | 55.13 Mn |
| Jun 30, 2023 | 102.70 Mn |
| Mar 31, 2023 | 91.53 Mn |
| Dec 31, 2022 | 84.73 Mn |
| Sep 30, 2022 | 111.57 Mn |
| Jun 30, 2022 | 167.01 Mn |
| Mar 31, 2022 | 135.89 Mn |
| Dec 31, 2021 | 270.00 Mn |
| Sep 30, 2021 | 432.59 Mn |
API Access
Cel Sci Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();